Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer

• All offer conditions fulfilled through regulatory approvals
• Upon completion of the offer, CVC secures a  minority stake of 23.11%^[1] in 
  CompuGroup Medical, shareholder around founding family Gotthardt retain majority stake with 50.12%
• Delisting offer planned shortly – no increase over tender offer price expected

Koblenz, Frankfurt - Caesar BidCo GmbH, a holding company owned by investment funds advised and managed by CVC Capital Partners ("CVC"), has announced, that the final outstanding regulatory approval for the completion of the voluntary public takeover offer to all shareholders of CompuGroup Medical SE & Co. KGaA ("CompuGroup Medical" or "CGM") has been granted and the completion of the offer will take place within the next eight banking days. Thus, all offer conditions have been fulfilled and the strategic partnership between CVC and the founding Gotthardt family as majority shareholder of CompuGroup Medical becomes effective upon the completion of the tender offer.

At the end of the additional acceptance period on 11 February 2025, the offer was accepted for 4,387,680 shares of CompuGroup Medical. This represents approximately 8.17% of the total share capital and voting rights. In addition, 14.94%^[2] of the total share capital and voting rights have been acquired outside the offer and are currently held by CVC directly and via instruments.

The shareholders around the founding family Gotthardt, who continue to control 50.12% of the total share capital and voting rights, retain their majority stake in CompuGroup Medical. CompuGroup Medical founder Frank Gotthardt remains Chairman of the Administrative Board. Prof. (apl.) Dr. med. Daniel Gotthardt continues to be Chief Executive Officer and member of the Administrative Board.

The partnership with CVC will support CompuGroup Medical's long-term innovation and growth strategy. Together, CompuGroup Medical and CVC aim to drive innovation in the healthcare sector to the benefit of patients and healthcare providers worldwide. The joint goal is to provide reliable support for medical professionals with state-of-the-art software products and strong customer service.

The completion of the offer will take place within the next eight banking days. CompuGroup Medical and CVC have agreed that CVC will submit a delisting offer immediately following the completion of the tender offer to take the company private. CVC does not intend to increase the offer price for purposes of the delisting offer.

Shareholders of CompuGroup Medical who tendered their shares in the public takeover offer will be paid the offer price of EUR 22.00 per share. Further information on the settlement and transfer of the tendered shares is available on the following website: www.practice-public-offer.com

[1] As of 16 April 2025

[2] As of 16 April 2025